Advertisement
Person › Details
Frédéric Revah (Généthon (FR))
Revah, Frédéric (Généthon 201001– CEO before Sepal Pharma CEO + Cerep)
Organisation | Généthon (FR) | |
Group | French Myopathy Association (AFM) | |
Product | gene therapy | |
Product 2 | DRUGS, ORPHAN | |
Record changed: 2019-06-10 |
Advertisement
More documents for Frédéric Revah
- [1] Yposkesi. (6/5/19). "Press Release: Servier Appoints Yposkesi for Lentiviral Vector GMP-Manufacturing in CAR-T Cell Development Technology". Suresnes & Corbeil-Essonnes....
- [2] Orchard Therapeutics Ltd.. (12/15/17). "Press Release: Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-linked Chronic Granulomatous Disease". London & Évry....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top